Legal Cognitive Dissonance Isn’t Just For Cannabis Anymore

If you fell asleep in a drug-induced haze 15 years ago and woke up today, you would be surprised at what you saw. Today, people walk into cannabis dispensaries in Florida and buy cannabis edibles with the same nonchalance with which, in an hour’s time when the munchies set in, they will walk into Publix and buy a family-sized package of Hostess cupcakes; you missed the years when they would walk into the dispensary and brandish their medical cannabis cards, grinning like the cat that ate the canary. Smoking a joint on a park bench is no longer the act of rebellion that it once was. In fact, daily cannabis use no longer connotes long-term resistance to an unjust world; instead, it has just become baked into our daily despair. This was not what the pioneers of the medical cannabis movement had in mind, in their moments of clarity. They were hoping that cannabis would bring relief from pain, nausea, and anxiety to patients with chronic illnesses, helping them to function in daily life, that cannabis would be a less debilitating alternative to the prescription drugs they previously took to manage their medical conditions. The legally accepted indications of pharmaceutical drugs are largely the result of clinical trials. The fact remains, though, that cannabis is a Schedule I controlled substance, and this presents obstacles to conducting medical research. As it is with cannabis, so it is with other Schedule I drugs with therapeutic potential, but a recent executive order provides an exception to some of these restrictions. If you are facing criminal charges for possession of a controlled substance that improves your health, contact a Tampa drug crime lawyer.

Executive Order Authorizes Medical Research on Psychedelics Officially Categorized as Schedule I Drugs

If you ask anyone who takes medication to treat chronic anxiety, depression, or post-traumatic stress disorder, they will tell you that it took a while before they started to feel improvement of their symptoms, or that it took a few tries to find a medication that was both effective and tolerable. Likewise, many people who have achieved sobriety have also experienced relapses, and the popular sobriety slogan “one day at a time” attests that anyone who is sober today is still at risk of relapsing tomorrow.

Enough anecdotal evidence suggests that short-term use of psychedelics such as psilocybin, or even LSD, can reduce symptoms of PTSD, and can reduce drug cravings in patients with a history of addiction. The logical next step is clinical trials to find a safe and effective treatment regimen with these drugs, but their Schedule I classification prevents this. In April 2026, President Trump signed an executive order authorizing several clinical trials on Schedule I psychedelics such as psilocybin and ibogaine.

Contact Tampa Criminal Defense Attorney Bryant Scriven

A criminal defense lawyer can help you get justice if you are facing criminal charges for possession of Schedule I controlled substances.  Contact Scriven Law in Tampa, Florida to schedule a consultation.

Source:

npr.org/2026/04/18/nx-s1-5789859/psychedelic-treatments-mental-health